tiprankstipranks
Trending News
More News >
Immunome (IMNM)
NASDAQ:IMNM
US Market
Advertisement

Immunome (IMNM) Technical Analysis

Compare
343 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Immunome’s (IMNM) Moving Averages Convergence Divergence (MACD) indicator is 1.52, suggesting Immunome is a Sell.
Immunome’s (IMNM) 20-Day exponential moving average is 14.13, while Immunome’s (IMNM) share price is $15.9, making it a Buy.
Immunome’s (IMNM) 50-Day exponential moving average is 12.22, while Immunome’s (IMNM) share price is $15.9, making it a Buy.

Immunome (IMNM) Pivot Points

Oct 24, 2025, 08:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.31
15.62
16.18
16.50
17.06
17.37
17.93
Fibonacci
15.62
15.96
16.16
16.50
16.83
17.04
17.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunome (IMNM) Moving Averages

Oct 24, 2025, 08:10 PM
Period
Simple
Exponential
MA5
16.21Sell
16.01Sell
MA10
15.40Buy
15.37Buy
MA20
13.81Buy
14.13Buy
MA50
11.41Buy
12.22Buy
MA100
10.50Buy
11.07Buy
MA200
9.65Buy
10.53Buy
Immunome’s (IMNM) 10-Day exponential moving average is 15.37, while Immunome’s (IMNM) share price is $15.9, making it a Buy.
Immunome’s (IMNM) 100-Day exponential moving average is 11.07, while Immunome’s (IMNM) share price is $15.9, making it a Buy.
Immunome’s (IMNM) stock price is $15.9 and Immunome’s (IMNM) 50-day simple moving average is 11.41, creating a Buy signal.
Immunome’s (IMNM) stock price is $15.9 and Immunome’s (IMNM) 100-day simple moving average is 10.50, creating a Buy signal.
Immunome’s (IMNM) stock price is $15.9 and Immunome’s (IMNM) 200-day simple moving average is 9.65, creating a Buy signal.

Immunome (IMNM) Technical Indicators

Oct 24, 2025, 08:10 PM
Name
Value
Implied Action
RSI (14)
64.90
Neutral
STOCH (9,6)
76.86
Neutral
STOCHRSI (14)
85.17
Sell
MACD (12,26)
1.52
Sell
ADX (14)
48.86
Neutral
Williams %R
-24.55
Buy
CCI (14)
106.54
Sell
ATR (14)
1.09
-
Ultimate Oscillator
62.98
Neutral
ROC
38.62
Buy
Immunome’s (IMNM) Relative Strength Index (RSI) is 64.90, creating a Neutral signal.
Immunome’s (IMNM) Trend Strength Indicator (ADX) is 48.86, creating a Neutral signal.
Immunome’s (IMNM) Commodity Channel Index (CCI) is 106.54, creating a Sell signal.
Immunome’s (IMNM) Price Rate of Change (ROC) is 38.62, creating a Buy signal.

FAQ

Is IMNM a Buy, Hold, or Sell?
Based on IMNM’s technical indicators, IMNM is a Buy.
    What is IMNM’s RSI (14)?
    IMNM’s RSI (14) is 64.90, which suggests IMNM is a Neutral.
      What is IMNM’s MACD?
      IMNM’s MACD is 1.52, which suggests IMNM is a Sell.
        What is IMNM’s 5-day moving average?
        IMNM’s 5-day moving average is 16.21, which suggests IMNM is a Sell.
          What is IMNM’s 20-day moving average?
          IMNM 20-day moving average is 13.81, which suggests IMNM is a Buy.
            What is IMNM’s 50-day moving average?
            IMNM’s 50-day moving average is 11.41, which suggests IMNM is a Buy.
              What is IMNM’s 200-day moving average?
              IMNM’s 200-day moving average is 9.65, which suggests IMNM is a Buy.
                What is IMNM’s Williams % R (14)?
                IMNM’s Williams % R (14) is -24.55, which suggests IMNM is a Buy.
                  What is IMNM’s CCI (14)?
                  IMNM’s CCI (14) is 106.54, which suggests IMNM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis